Author Correction: Direct and Selective Pharmacological Disruption of the YAP-TEAD Interface by IAG933 Inhibits Hippo-dependent and RAS-MAPK-altered Cancers

Overview

Journal Nat Cancer

Specialty Oncology

Date 2024 Jun 17

PMID 38886525

Authors

Emilie A Chapeau

Laurent Sansregret

Giorgio G Galli

Patrick Chene

Markus Wartmann

Thanos P Mourikis

Patricia Jaaks

Sabrina Baltschukat

Ines A M Barbosa

Daniel Bauer

Saskia M Brachmann

Clara Delaunay

Claire Estadieu

Jason E Faris

Pascal Furet

Stefanie Harlfinger

Andreas Hueber

Eloisa Jimenez Nunez

David P Kodack

Emeline Mandon

Typhaine Martin

Yannick Mesrouze

Vincent Romanet

Clemens Scheufler

Holger Sellner

Christelle Stamm

Dario Sterker

Luca Tordella

Francesco Hofmann

Nicolas Soldermann

Tobias Schmelzle

Affiliations

Soon will be listed here.

Citing Articles

Oncofetal reprogramming drives phenotypic plasticity in WNT-dependent colorectal cancer.

Mzoughi S, Schwarz M, Wang X, Demircioglu D, Ulukaya G, Mohammed K Nat Genet. 2025; 57(2):402-412.

PMID: 39930084 PMC: 11821538. DOI: 10.1038/s41588-024-02058-1.

YAP-TEAD inhibition is associated with upregulation of an androgen receptor mediated transcription program providing therapeutic escape.

Alva-Ruiz R, Watkins R, Tomlinson J, Yonkus J, Abdelrahman A, Conboy C FEBS Open Bio. 2024; 14(11):1873-1887.

PMID: 39300603 PMC: 11532981. DOI: 10.1002/2211-5463.13901.

Diffuse Gastric Cancer: A Comprehensive Review of Molecular Features and Emerging Therapeutics.

Wu L, Jang S, Shapiro C, Fazlollahi L, Wang T, Ryeom S Target Oncol. 2024; 19(6):845-865.

PMID: 39271577 PMC: 11557641. DOI: 10.1007/s11523-024-01097-2.